SUMMARY Factors possibly influencing the development of diabetic retinopathy were studied in 112 randomly selected type I diabetics having no or minimal retinopathy (group A) and in 82 type 1 diabetics with known severe diabetic retinopathy. The latter comprised those with severe background retinopathy (group B, n= 17) and those having proliferative retinopathy without (group C, n=38) and with (group D, n=27) diabetic nephropathy. Nonretinopaths (group A) were of similar sex ratio, body weight, and age at diagnosis of diabetes but had been diabetic longer (p<O0OO1) and were thus older (p<OO01) than retinopaths (groups B-D). The distribution of HLA antigens of the A, B, and C loci was similar in nonretinopaths and retinopaths with the exception that HLA B7 showed a reduced (p<O0O5) prevalence in the retinopaths (6% versus 17%) and was singularly underrepresented in group D, where no patients had this antigen. Mean postprandial plasma glucose and HbA, concentrations were higher (p<O0O1 and p<O0OO1) and cigarette smoking was more prevalent (p<OO1) in the retinopathy groups B-D than in group A. Systolic and diastolic blood pressures were similar in groups A-C, with higher (p<O0OO1) values only in group D. There was no association between insulin antibody binding in the serum or measurable plasma C-peptide immunoreactivity and retinopathy status. The risk of development of diabetic retinopathy in type I diabetes may be related to HLA-associated genetic factors and to cigarette smoking.
In order to evaluate the possible factors which may influence the incidence, severity and progress of retinopathy in type I diabetics we have examined the frequencies of the HLA antigens of the A, B, and C loci, selecting only those diabetics who had either developed severe diabetic retinopathy or exhibited an apparent immunity to the development of other than very mild background diabetic retinopathy. Since duration of diabetes is possibly the most important determinant of the development of diabetic retinopathy, we have taken particular care to select retinopaths of short duration of diabetes and nonretinopaths of long duration of diabetes. In addition to considering HLA antigen frequencies we have compared the 2 groups of diabetics in respect of Correspondence to Dr R. S. Gray, Diabetic and Dietetic Department, Royal Infirmary, Edinburgh EH3 9YW. postprandial plasma glucose concentration, total glycosylated haemoglobin (HbA,), insulin antibody binding by serum, prevalence of diastolic and systolic hypertension, and smoking history. Finally, we have shown that all subjects studied were type 1 diabetics by confirming an absent or only just measurable postprandial C-peptide concentration in the plasma. We thus avoided the risk of inadvertently including subjects with 'maturity onset diabetes of the young' in the group of nonretinopaths. diabetes before the age of 35 years and having been treated with insulin from the outset.
Nonretinopaths. One hundred and twelve unrelated diabetics (49 males, 63 females) were randomly selected from a cohort of patients who are the subject of a long-term prospective study of Owing to the method of patient selection nonretinopaths had been diabetic longer (p<0 001) and were older (p<0-001) than retinopaths, but there was no significant difference in sex ratio, daily insulin dose, percentage of ideal body weight, insulin regimen, or family history of diabetes (Table 1) between nonretinopaths and retinopaths. The visual acuity in each eye of proliferative retinopaths was worse (p<0-001 and <0-001) than that of nonretinopaths (Table 1) .
The prevalence of proteinuria and renal failure (serum creatinine >150 ,umol/l) in nonretinopaths and retinopaths is also shown in Table 1 . Patients with persistent proteinuria or the nephrotic syndrome (without evidence of other than diabetic renal disease) are defined as having diabetic nephropathy.
HLA TYPING Table 2 shows the distribution of HLA antigens in the subjects studied which are reported to be over-or None of the 27 patients in group D exhibited HLA B7. The frequencies of inferred homozygosity of HLA B7 and B8 were 3% and 15% in diabetic nonretinopaths, 0% and 15% in diabetic retinopaths, and 2% and 1% in nondiabetic controls.
HbA, AND POSTPRANDIAL PLASMA GLUCOSE CONCENTRATIONS Table 3 shows the mean HbA, and postprandial plasma glucose values of diabetics in groups A-D. There was no significant difference between plasma glucose values of patients in groups B-D whose overall mean value (16&4±8-8 mmol/l) was significantly higher (p<0-01) than that of patients in group A (12-6+5-8 mmol/l). Similarly, the mean HbA, value of patients in groups B-D (13-8±24%) was significantly higher (p<0 001) than that (12-1--18%) of patients in group A. There was a significant correlation between plasma glucose and HbA, when retinopaths and nonretinopaths were considered together (r=0A48, p<0 001) or separately (r=0-46, p<0001; T=0-22, p<001 (Table 3) . However, insulin antibody binding correlated significantly with age at study (r=0-18, p<O-001) and duration of diabetes (T=0-16, p<001). Mean insulin antibody binding in patients taking once daily insulin (25-4±16-8%) was higher (p<0001) than in those taking twice daily insulin (16-7±14%), while patients taking conventional beef insulin had higher (p<0001) insulin antibody binding (238±l15-9%) than those taking highly purified pork insulin (15-6±15-2%). There was no significant relationship between insulin antibody binding and daily insulin dose or plasma C-peptide concentration. Wilcoxon rank sum tests show mean insulin antibody binding to be lower (p<001) in HLA B8 positive diabetics (18-2%) than in HLA B8 negative diabetics (25 0%) and to be higher (p<005) in HLA B15 Grav, Starkev, Rainbow, Kurtz, Abdel-Khalik, Urbaniak, Elton, Duncan, and Clarke positive diabetics (27-1%) than in HLA B 15 negative diabetics (204%). The association between B15 and high insulin antibody binding was independent of the association between B8 and low insulin antibody binding. Mean insulin antibody binding was not significantly different in B7 positive (26-9%) and negative diabetics (20(8%).
C-PEPTIDE
None of the nonretinopaths studied had a plasma C-peptide concentration greater than 0-29 nmol/l. No significant difference was observed in the frequency with which a measurable C-peptide concentration was found in patients of groups A, B, C, and D (30, 47, 25, and 13%). Table 3 shows that the mean plasma C-peptide concentration was not significantly different within groups A-D.
Bl OOD PRESSURE There was no significant difference in the prevalence of systolic or diastolic hypertension (>155 and >85 mmHg) in patients of groups A-C (Table 3) . However, the prevalences of systolic and diastolic hypertension in group D (41 and 56%) were significantly greater (p<0(0)l and <0-001) than in groups A-C (10 and 12%). Table 3 shows the proportions of patients in groups A-D who were smoking cigarettes at the time of study and provides details of daily number of cigarettes smoked and duration of smoking in past and present smokers. Although retinopaths (groups B-D) included more (p<0-01) smokers (60%) than nonretinopaths (38%), this difference was mainly accounted for by the high prevalence of smoking in group D (69%), being significantly greater (p<005) than in the other 3 groups of diabetics (44%). These differences were not accounted for by the age differences in patients in groups A-D. There was no significant difference between the prevalence of smoking in patients of groups B and C combined (56%) and that of patients in group A or group D. The significantly longer smoking history in group A is presumably due to the greater mean age of patients in this group.
SMOKING

Discussion
A relationship between diabetic microangiopathy and an HLA antigen (or antigens) of the A, B, and/or C loci has been proposed by several authors,'-" whose findings are, however, contradictory owing to the heterogeneity of populations under consideration, the small numbers of patients studied, together with the absence or lack of adequate control data. Barbosa et al. 4 The present studv suggests that the risk of development of diabetic microangiopathv is related not only to HLA associated genetic factors but also to cigarette smoking.
